Welcome to the
European Biotechnology Network!

The European Biotechnology Network is dedicated to facilitating co-operation between professionals in biotechnology and the life sciences all over Europe.

The non-profit organisation brings research groups, universities, SMEs, large companies and indeed all actors in biotechnology together to build and deliver partnerships.

Latest Catch

  • © Helmholtz-Zentrum Dresden-Rossendorf

    €1bn in EU funding for health and raw materials

    16.12.2014 Two consortia combined of 144 European companies, research institutes and universities have been selected for funding by the EIT in the areas of health and raw materials. Both clusters are set to acquire €1.1bn over the next seven years.

    The European Institute of Innovation and Technology (EIT) has selected the consortium InnoLife as the Knowledge and Innovation Community (KIC) for EIT Health, which will receive a total of €700m. The funding from the EU will be invested over a period of seven years and will be supplemented by financing from the private sector interested in start-ups and applied research.

    The European branch of InnoLife will be headquartered in Munich at the Technical University and will coordinate the consortium partners, which consists of 50 core players and 90 associated partners from 16 countries. “Innolife’s goal is to promote entrepreneurship and develop innovations in healthy living and active ageing, providing Europe with new opportunities and resources by delivering products, services and concepts that will improve quality of life and contribute to the sustainability of healthcare across Europe,” said Dr. Ursula Redeker from Roche Diagnostics GmbH in Munich, the coordinating partner. Other big players include Abbott Laboratories from Spain, Roche, Siemens and Philips together with research institutes such as the French National Institute of Health and Medical Research (INSERM), the University of Oxford and Imperial College London.

    The second cluster is RawMatTERS, bringing together a consortium of 116 partner organisations from 22 EU member states. RawMatTERS specialises in resource efficiency and will receive €410m in funding. The partners include the KGHM Polish Copper S.A. from Poland, the RISE Research Institute of Sweden and the University of Milano-Bicocca from Italy.

    As with InnoLife, the consortium will be coordinated in Germany at the Helmholz-Zentrum Dresden-Rossendorf. “The EIT will enable our partnership to make a real societal change and to turn the challenge of raw materials dependence into a strategic strength for Europe,” said Jens Gutzmer from the Helmholz research centre. We want to focus on sustainable growth and job creation by boosting start-ups, SMEs and education. By 2022, we are aiming to create, among others, 64 start-ups and 5 new primary/secondary sources of critical raw materials.”

    The EIT will provide both winning clusters with a start-up grant of up to €4m to ensure a smooth and rapid start to their work in the first year.

    © european-biotechnology-news.com/jc

    The Latest Catch is brought to you by European Biotechnology News

Featured Events

Our Corporate Members are

Calendar

All events

Address

European Biotechnology Network

Avenue de Tervueren 13
1040 Brussels, Belgium

Tel: +32 27 33 72 37

office@european-biotechnology.net

Membership

Join the European Biotechnology Network!

Individual Membership for natural persons is free, while Corporate Membership, for companies, institutions and research groups start from €500 p.a.

Click here to apply for network membership!

Funding Hub Strategic Partnership

European Biopharmaceutical Enterprises